Healwell AI Inc. (HWAIF) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
Market cap $168M is the value of all shares combined.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerHealwell AI Inc. (HWAIF) trades at $0.556 with MoonshotScore 65/100 (Grade B+). Healwell AI Inc. is a Toronto-based healthcare technology company established in 2012, specializing in AI-powered decision support for preventative care. Market cap: $168M, Sector: Healthcare.
Price as of Sep 11, 2026 · Last analyzed: Jun 14, 2026Analyst Coverage for HWAIF: HWAIF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates HWAIF against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
These figures come from statements filed 12 months ago — the most recent this company has published.
HWAIF: 1/3 scored disciplines lean bullish. Dominant signal: Ken Griffin bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Healwell AI Inc. (HWAIF) Healthcare & Pipeline Overview
Healwell AI Inc. leverages artificial intelligence and data science to deliver an AI-powered decision support platform for preventative healthcare professionals. Established in 2012 and rebranded in 2023, the Toronto-based company maintains a strategic alliance with WELL Health Technologies Corp to advance AI solutions within the healthcare sector.
What Is the Investment Thesis for HWAIF?
Healwell AI Inc. is positioned within the expanding artificial intelligence in healthcare sector, specifically targeting preventative care with its AI-powered decision support platform. The strategic alliance with WELL Health Technologies Corp represents a significant value driver, potentially accelerating technology development and market penetration for its AI solutions. While the company exhibits a strong Gross Margin of 56.1%, indicating efficient core operations, it currently operates at a Profit Margin of -31.2% and an ROE of -30.0%, reflecting ongoing investments in growth and technology. With a market capitalization of $168M and a Debt-to-Equity ratio of 71.40%, HWAIF carries characteristics of a growth-oriented company in its investment phase. The ability to commercialize its technology effectively and achieve sustainable revenue growth will be critical for future performance. As an OTC-listed stock, investors should also consider the inherent risks associated with smaller, less liquid companies, including potential volatility and disclosure limitations.
Based on FMP financials and quantitative analysis
HWAIF Key Highlights
Market Capitalization stands at $168M, categorizing Healwell AI Inc. as a small-cap entity within the healthcare technology sector.
- Gross Margin is reported at 56.1%, indicating a strong ability to manage the cost of services relative to revenue generated from its AI-powered platform.
- Profit Margin is currently -31.2%, reflecting the company's ongoing investment phase in research, development, and market expansion, leading to unprofitability.
- Return on Equity (ROE) is -30.0%, consistent with the negative profit margin and indicating that the company is currently incurring losses relative to shareholder equity.
- Debt-to-Equity ratio is 71.40%, suggesting a notable reliance on debt financing to fund operations and growth initiatives.
Who Are HWAIF's Competitors?
HWAIF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AIRS AirSculpt Technologies, Inc. | $2.58 | -0.96% | $182M | 335-pillar |
| JYNT The Joint Corp. | $8.03 | -0.74% | $114M | 705-pillar |
| AUNA Auna S.A. | $5.22 | +0.97% | $386M | 715-pillar |
| CYH Community Health Systems, Inc. | $2.94 | -0.51% | $414M | 365-pillar |
| BTMD biote Corp. | $1.31 | -9.66% | $57.8M | 665-pillar |
| ALR AlerisLife Inc. | $1.32 | 0.00% | $44.2M | — |
| DCGO DocGo Inc. | $0.37 | -1.30% | $36.1M | — |
| CCEL Cryo-Cell International, Inc. | $4.13 | +0.49% | $33.3M | 315-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are HWAIF's Key Strengths?
Specialized focus on AI and data science for preventative care, addressing a critical market need.
- Strategic alliance with WELL Health Technologies Corp, offering potential for accelerated development and market expansion.
- Strong Gross Margin of 56.1%, indicating efficient core service delivery.
- Established presence since 2012, providing a foundation of experience and market understanding.
What Are HWAIF's Weaknesses?
Current unprofitability, reflected in a -31.2% Profit Margin and -30.0% ROE.
- Reliance on debt financing with a Debt-to-Equity ratio of 71.40%.
- Limited public information on specific product details and commercialization progress.
- Operates as an OTC-listed stock, which can present challenges related to liquidity and investor perception.
What Could Drive HWAIF Stock Higher?
HWAIF catalyst: Successful commercialization and widespread adoption of its AI-powered decision support platform within healthcare facilities, leading to increased revenue streams.
- Achievement of key milestones or expansion initiatives stemming from the strategic alliance with WELL Health Technologies Corp, potentially including new product integrations or market penetration.
- Continued advancements and enhancements to its core AI and data science technologies, improving the efficacy and competitive advantage of its preventative care solutions.
- Announcement of new partnerships or customer acquisitions that significantly expand its market reach and user base for its AI platform.
- Positive financial reporting demonstrating progress towards profitability and sustainable revenue growth, which could improve investor confidence.
What Are the Key Risks for HWAIF?
Financial-distress signal — its Altman Z-Score of 0.45 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-31.8%) — the business is not currently generating profit on shareholder capital.
- Inconsistent delivery — missed Wall Street EPS estimates in 6 of the last 8 reported quarters.
- The company's current unprofitability, as indicated by a -31.2% Profit Margin and -30.0% ROE, poses a risk to long-term financial sustainability if not reversed.
- Significant competition within the AI in healthcare sector from both established technology firms and other specialized startups, potentially limiting market share and pricing power.
- Risks associated with being an OTC-listed stock, including lower liquidity, potential price volatility, and challenges in accessing capital markets compared to major exchanges.
- Dependence on the successful execution and expansion of its strategic alliance with WELL Health Technologies Corp; any disruption to this partnership could impact growth plans.
- Regulatory changes or challenges in the healthcare technology sector, particularly concerning data privacy, AI ethics, and medical device approvals, could impact operations and product development.
What Are the Growth Opportunities for HWAIF?
- **Expansion of AI-Powered Decision Support Platform Adoption:** The global market for AI in healthcare is projected to grow significantly, driven by increasing demand for advanced diagnostic tools and personalized medicine. Healwell AI Inc.'s AI-powered decision support platform for preventative care is well-positioned to capitalize on this trend. By enhancing the platform's capabilities, expanding its feature set, and demonstrating clear ROI to healthcare professionals and institutions, the company can drive wider adoption. This expansion could involve targeting new clinic networks, hospital systems, or even international markets, with a timeline for substantial market penetration within the next 3-5 years, leveraging its specialized focus on preventative care.
- **Leveraging the Strategic Alliance with WELL Health Technologies Corp:** The strategic alliance with WELL Health Technologies Corp provides Healwell AI Inc. with a significant channel for growth. This partnership can facilitate access to WELL Health's extensive network of clinics and digital health assets, enabling accelerated deployment and validation of Healwell AI's solutions. Collaborative development efforts can lead to integrated offerings that are more compelling to the market. The alliance can also provide shared resources for research and development, potentially reducing time-to-market for new features or products. This collaboration is an ongoing opportunity, with key milestones expected over the next 2-4 years as integrated solutions are rolled out.
- **Development and Commercialization of New AI-Driven Preventative Tools:** Building on its core expertise in AI and data science for preventative care, Healwell AI Inc. has the opportunity to develop and commercialize additional AI-driven diagnostic or risk assessment tools. This could include AI models for predicting disease onset, personalized health recommendations, or tools for early detection of chronic conditions. The market for such innovative preventative solutions is vast, driven by an aging global population and rising healthcare costs. Investing in R&D to create proprietary algorithms and intellectual property in these areas can secure future revenue streams, with new product launches potentially occurring within a 3-6 year horizon.
- **Penetration into Adjacent Healthcare Segments:** While currently focused on preventative care, Healwell AI Inc. possesses the foundational AI and data science capabilities to expand into adjacent healthcare segments. This could include applying its technology to improve operational efficiencies in clinics, enhance patient engagement platforms, or even support clinical trial recruitment and data analysis. The versatility of AI in healthcare allows for diversification of revenue streams and market reach. Identifying and strategically entering these new segments, potentially through partnerships or targeted acquisitions, could unlock significant growth over a 5-7 year period, broadening its total addressable market.
- **Data Monetization and Insights Generation:** Healwell AI Inc.'s platform, by processing vast amounts of healthcare data to provide decision support, inherently generates valuable insights. There is a growth opportunity in ethically and securely monetizing anonymized and aggregated data insights for pharmaceutical research, public health initiatives, or healthcare policy development. This could involve offering data analytics services or licensing de-identified datasets to third parties. The market for healthcare data analytics is substantial, and HWAIF's unique position in preventative care data could provide a competitive edge, creating a new, high-margin revenue stream that could mature over the next 4-6 years.
What Are HWAIF's Competitive Advantages?
- Proprietary AI and data science algorithms specifically tailored for preventative healthcare decision support.
- Strategic alliance with WELL Health Technologies Corp, providing enhanced market access and collaborative development capabilities.
- Accumulated expertise and data within the preventative care domain since its founding in 2012.
- Focus on a niche yet growing segment of healthcare AI, allowing for specialized development and market positioning.
What Does HWAIF Do?
Healwell AI Inc., a healthcare technology enterprise headquartered in Toronto, Canada, was established in 2012 with a core mission to enhance preventative care through advanced artificial intelligence and data science. The company's primary offering is an AI-powered decision support platform, meticulously designed to assist healthcare professionals in optimizing patient outcomes and streamlining clinical workflows. This platform is central to its strategy of improving early detection and proactive health management. A significant component of Healwell AI Inc.'s operational framework is its strategic alliance agreement with WELL Health Technologies Corp. This partnership is specifically geared towards accelerating the development and broader expansion of AI-driven healthcare solutions, leveraging the combined expertise and resources of both entities to penetrate the market more effectively. The company's evolution saw a notable milestone in October 2023 when it officially adopted its current name, Healwell AI Inc., transitioning from its previous identity as MCI Onehealth Technologies Inc. This rebranding underscored its sharpened focus on AI and data science in the healthcare domain. With approximately 350 employees, Healwell AI Inc. positions itself at the intersection of technological innovation and critical healthcare needs, aiming to address the growing demand for intelligent, data-driven tools in preventative medicine.
What Products and Services Does HWAIF Offer?
- Develops and provides an AI-powered decision support platform for healthcare professionals.
- Specializes in leveraging artificial intelligence and data science to enhance preventative care.
- Aims to improve early detection and proactive health management through technology.
- Operates in the healthcare technology sector, focusing on AI applications.
- Maintains a strategic alliance with WELL Health Technologies Corp to accelerate AI healthcare solutions.
- Focuses on creating tools that assist healthcare providers in making informed decisions.
- Utilizes data science to derive actionable insights for patient care.
- Contributes to the digital transformation of the medical care facilities industry.
How Does HWAIF Make Money?
- Likely generates revenue through subscriptions or licensing fees for its AI-powered decision support platform to healthcare professionals and institutions.
- May offer service fees for specialized AI-driven analytics or custom solution deployments.
- Potentially benefits from its strategic alliance with WELL Health Technologies Corp through joint ventures, revenue sharing, or expanded market access.
- Focuses on delivering value by enhancing preventative care outcomes and operational efficiency for its clients.
What Industry Does HWAIF Operate In?
Healwell AI Inc. operates within the dynamic and rapidly evolving healthcare technology industry, specifically focusing on the application of artificial intelligence in medical care facilities. The broader healthcare sector is experiencing a significant shift towards digital transformation, with AI and data science emerging as pivotal tools for improving diagnostics, treatment efficacy, and operational efficiencies. The demand for AI solutions in healthcare is growing, driven by the need to manage increasing patient data, reduce costs, and enhance preventative care outcomes. Healwell AI Inc. positions itself by specializing in AI-powered decision support for preventative care, a segment poised for substantial growth as healthcare systems globally emphasize proactive health management. The competitive landscape includes both established healthcare IT giants and numerous agile startups, all vying for market share in various AI applications. Healwell AI Inc.'s strategic alliance with WELL Health Technologies Corp provides a distinct advantage in navigating this competitive environment, offering potential for accelerated development and expanded market reach.
Who Are HWAIF's Key Customers?
- Healthcare professionals, including doctors, nurses, and specialists.
- Medical clinics and primary care facilities.
- Larger healthcare systems and hospitals seeking AI-driven preventative solutions.
- Potentially, partners like WELL Health Technologies Corp for integrated solutions.
Research confidence
Enough evidence to be useful, with gaps worth knowing about.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 73 days ago
- ● No analyst coverage
Why 65?
This rating comes from our nine-signal model, which produces a score but not a per-factor breakdown. The sector-relative five-pillar model, which explains its own contributions, does not cover this listing yet. How the score is built →
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 65 |
| 2026-08-26 | 65 |
| 2026-08-29 | 65 |
| 2026-09-01 | 65 |
| 2026-09-04 | 65 |
| 2026-09-07 | 65 |
| 2026-09-10 | 65 |
What changed?
The score has stayed at 65.
Over the same 18 days the stock moved +1.6%.
Healwell AI Inc. (HWAIF) Valuation Context
Valued at $168M, HWAIF is classified as a micro-cap stock. Relative to its peer group, HWAIF's quantitative score of 65/100 is above the peer average of 51/100.
HWAIF Revenue & Earnings Trend
In Q2 FY2026, HWAIF generated $33.0M in top-line revenue, marking a sequential decrease of 1.0%. The company recorded net income of $6.4M, with diluted EPS of $0.02. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Healthcare. Across the four most recent quarters, HWAIF averaged $-0.03 in diluted EPS.
Company Profile
Healwell AI Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Toronto, CA. The company is led by CEO James Samuel Lee. HWAIF has traded publicly since 2021.
Key Financial Metrics
Return on equity for Healwell AI Inc. stands at -31.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -14.4%, showing how much profit it generates from its asset base. Its free cash flow yield is -5.3%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.89 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -17.9%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
Healwell AI Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 0.45 places it in the distress zone, a signal of elevated financial risk.
Earnings Track Record
Healwell AI Inc. has missed Wall Street's EPS estimate in 6 of its last 8 reported quarters — a mixed record worth weighing. Reported results have landed about 103.4% below estimates on average.
HWAIF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Specialized focus on AI and data science for preventative care, addressing a critical market need.
- Strategic alliance with WELL Health Technologies Corp, offering potential for accelerated development and market expansion.
- Strong Gross Margin of 56.1%, indicating efficient core service delivery.
- Established presence since 2012, providing a foundation of experience and market understanding.
Bear Case
- Current unprofitability, reflected in a -31.2% Profit Margin and -30.0% ROE.
- Reliance on debt financing with a Debt-to-Equity ratio of 71.40%.
- Limited public information on specific product details and commercialization progress.
- Operates as an OTC-listed stock, which can present challenges related to liquidity and investor perception.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 FY2026 | C$33M | C$6M | C$0.02 |
| Q1 FY2026 | C$33M | -C$7M | -C$0.02 |
| Q4 FY2025 | C$32M | -C$1M | -C$0.0042 |
| Q3 FY2025 | C$30M | -C$28M | -C$0.12 |
Q2 FY2026 · filed 30 Jun 2026 · SEC EDGAR →
Based on FMP financials and quantitative analysis · Reported in CAD
HWAIF Latest News
-
HEALWELL's DARWEN(TM) to Power AI-Driven Clinical Trial Matching for WELLTRUST(TM), a Network of Over 100,000 Consented Patients
newsfilecorp.com · Sep 8, 2026
-
WELL Health Announces WELLTRUST(TM) Surpasses 100,000 Patient Consents
newsfilecorp.com · Sep 8, 2026
-
HEALWELL to Deploy AI-Powered SMART Search and SMART Summary Across Statewide U.S. Health Information Exchange
newsfilecorp.com · Sep 1, 2026
-
HEALWELL AI's DARWEN(TM) AI Platform Nominated for 2026 International Prix Galien, the Global "Best of the Best" in Life Sciences Innovation
newsfilecorp.com · Aug 19, 2026
HWAIF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for HWAIF.
Price Targets
Wall Street price target analysis for HWAIF.
HWAIF MoonshotScore
What does this score mean?
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. HWAIF scores 65/100 (Grade B+): the number comes from the legacy nine-factor engine (quantitative signals from revenue growth to news sentiment), written once, not refreshed.
Latest News
HEALWELL's DARWEN(TM) to Power AI-Driven Clinical Trial Matching for WELLTRUST(TM), a Network of Over 100,000 Consented Patients
WELL Health Announces WELLTRUST(TM) Surpasses 100,000 Patient Consents
HEALWELL to Deploy AI-Powered SMART Search and SMART Summary Across Statewide U.S. Health Information Exchange
HEALWELL AI's DARWEN(TM) AI Platform Nominated for 2026 International Prix Galien, the Global "Best of the Best" in Life Sciences Innovation
Leadership: Aaron Leibtag
Chief Executive Officer
Aaron Leibtag serves as the Chief Executive Officer of Healwell AI Inc. His leadership role encompasses overseeing the company's strategic direction and operational execution, managing a team of approximately 350 employees.
Track Record: Under Aaron Leibtag's leadership, Healwell AI Inc. underwent a significant strategic transformation, culminating in its rebranding from MCI Onehealth Technologies Inc. in October 2023, solidifying its focus on artificial intelligence. He has been instrumental in guiding the company's specialization in AI and data science for preventative care and has overseen the establishment of a strategic alliance with WELL Health Technologies Corp, a key initiative aimed at accelerating the development and expansion of AI-driven healthcare solutions.
HWAIF OTC Market Information
Healwell AI Inc. trades on the OTC market under the 'OTC Other' tier. This classification typically applies to companies that do not meet the listing requirements for higher OTC tiers like OTCQX or OTCQB, nor for major exchanges such as the NYSE or NASDAQ. Companies in the 'OTC Other' tier often have limited public disclosure and may not regularly file financial reports with the SEC, which can lead to less transparency compared to exchange-listed or higher-tier OTC securities. This tier is generally associated with smaller, less liquid companies.
- OTC Tier: OTC Other
- Lower liquidity and wider bid-ask spreads, making it difficult to buy or sell shares efficiently.
- Limited or inconsistent public disclosure, hindering comprehensive financial analysis and transparency.
- Increased price volatility due to lower trading volumes and fewer market participants.
- Potential for limited analyst coverage and institutional investment, impacting market awareness and valuation.
- Higher susceptibility to market manipulation due to less stringent regulatory oversight compared to major exchanges.
- Verify all available financial statements and reports, even if disclosure is limited.
- Thoroughly research the company's business model, products, and strategic partnerships, such as with WELL Health Technologies Corp.
- Assess the management team's background, experience, and track record in the healthcare technology sector.
- Evaluate the competitive landscape and the company's unique selling propositions within the AI in healthcare market.
- Investigate any regulatory compliance issues or legal proceedings.
- Understand the commercialization strategy for its AI platform and potential for revenue growth.
- Analyze the company's capital structure, debt levels, and ability to secure future funding.
- Strategic alliance with WELL Health Technologies Corp, a recognized entity in the healthcare sector, lends credibility.
- Established in 2012, indicating a history of operations and evolution within the healthcare technology space.
- Clear business description focused on AI and data science for preventative care, addressing a high-growth sector.
- Reported employee count of 350 suggests a substantial operational footprint for an OTC-listed company.
What Investors Ask About Healwell AI Inc. (HWAIF) — Healthcare
What does the AI Score mean for HWAIF?
HWAIF holds an AI Score of 65/100 (Grade: B+). This is an educational research signal, not a buy or sell recommendation. The number comes from the legacy nine-factor engine (quantitative signals from revenue growth to news sentiment), written once, not refreshed.
Is HWAIF a good stock?
Stock Expert AI does not rate HWAIF buy, sell or hold. Healwell AI Inc. carries a MoonshotScore of 65/100 on the legacy nine-factor engine, a research rating against its peers. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What does Healwell AI Inc. do?
Healwell AI Inc. is a healthcare technology company that specializes in leveraging artificial intelligence and data science to enhance preventative care.
What are the key factors to evaluate for HWAIF?
Healwell AI Inc. (HWAIF) holds an AI score of 65/100 (moderate). Market Capitalization stands at $168M, categorizing Healwell AI Inc. as a small-cap entity within the healthcare technology sector. Not financial advice.
How frequently does HWAIF data refresh on this page?
HWAIF's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven HWAIF's recent stock price performance?
Healwell AI Inc. (HWAIF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized focus on AI and data science for preventative care, addressing a critical market need. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider HWAIF overvalued or undervalued right now?
Healwell AI Inc. (HWAIF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of HWAIF?
Yes, most major brokerages offer fractional shares of Healwell AI Inc. (HWAIF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track HWAIF's earnings and financial reports?
Healwell AI Inc. (HWAIF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for HWAIF earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- All information is derived directly from the provided source data.
- CEO's tenure years are not provided in the source data.